Get startedLog in
    Picture of Arcutis Biotherapeutics logo

    ARQT — Arcutis Biotherapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Palvella Therapeutics Strengthens Leadership With Appointment Of Accomplished Scientist And Biopharmaceutical Executive David W. Osborne, Ph.D. As Chief Innovation Officer

    Picture of Arcutis Biotherapeutics logoArcutis Biotherapeutics
    03/09/2025 13:31
    Sept 3 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O:

PALVELLA THERAPEUTICS STRENGTHENS LEADERSHIP WITH APPOINTMENT OF ACCOMPLISHED SCIENTIST AND BIOPHARMACEUTICAL EXECUTIVE DAVID W. OSBORNE, PH.D. AS CHIEF INNOVATION OFFICER

Source text: ID:nGNX7zqn0P

Further company coverage: ARQT.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Arcutis Biotherapeutics

    See all news